期刊文献+

慢性乙型重型肝炎患者预后影响因素的分析 被引量:3

Analysis on Factors Affecting the Prognosis of Patients with Severe Chronic Hepatitis B
暂未订购
导出
摘要 目的研究影响慢性乙型重型肝炎患者预后的重要因素,并建立预后评估模型。方法收集2009年1月至2012年1月常州市第三人民医院确诊为慢性乙型重型肝炎的100例患者的临床资料和实验室数据,进行单因素和多因素的Logistic回归分析。结果单因素分析显示,存活组和死亡组患者的总胆红素(TBil)、凝血酶原时间(PT)、谷氨酰转肽酶(γ-GT)、血清总胆固醇、血清钠浓度、血小板(PLT)差异有统计学意义(P<0.05);多因素分析显示该病的预后与TBil、PT、γ-GT和PLT有关。结论γ-GT、TBil、PT和PLT可作为慢性乙型重型肝炎患者预后的判定因素,对临床有指导价值。 Objective To analyze the factors which may affect the prognosis of severe chronic hepatitis B, and to develop a prognostic model. Methods From January 2009 to January 2012, 100 in-patients with chronic severe hepatitis B of the Third People's Hospital of Changzhou were selected. The main clinical and laboratory variables were analyzed as predictive factors of survival with Logistic univariate and multivariate regression. Results Univa- riate analysis indicated TBil, PT, r-GT CHO, Na + and PLT were significantly different between the survival group and death group( P 〈0.05 ). Multivariate analysis indicated that the prognosis of the disease was correlated with TBil,PT,r-GT and PLT. Conclusion Levels of r-GT,TBiI,PT and PLT can be used as predicting factors for the prognosis of patients with severe chronic hepatitis B ,which have guidance value for the clinical practice.
出处 《医学综述》 2013年第17期3215-3216,共2页 Medical Recapitulate
关键词 慢性乙型肝炎 预后 因素 Chronic hepatitis B Prognosis Factors
  • 相关文献

参考文献8

二级参考文献46

共引文献1878

同被引文献49

  • 1胆汁淤积性肝病诊断治疗专家委员会.胆汁淤积性肝病诊断治疗专家共识2013[J].中华肝脏病杂志,2014,22(1). 被引量:26
  • 2叶维法.临床肝胆病学[M].3版.天津:天津科学技术出版社,2008:299-300.
  • 3Weich V, Herrmann E, Chung TL, et al. The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection[J]. J Gastroenterol,2011,46( 12): 1427-1436.
  • 4Coban S, Idilman R, Erden E, et al. Gamma-glutamyl transpeptidase in predicting sustained virological response in individuals with chronic hepatitis C[J]. Hepatogastroenterology,2011,58( 109): 1301 - 1306.
  • 5Everhart JE, Wright EC. Association of γ-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV)[J]. Hepatology,2013,57(5):1725-1733.
  • 6European Association for the Study of the Liver. EASL clinical practice guidelines:management of cholestatic liver diseases[J]. J Hepatol,2009,51 (2):237-267.
  • 7Michael Brown J, Ball JG, Wright MS. Novel protective mechanisms for S-adenosyl-L-methionine against acetaminophen hepatotoxicity: improvement of key antioxidant enzymatic function[J]. Toxicol Lett,2012,212(3):320-328.
  • 8Vardar R, Vardar E, Demiri S, et al. Is there any non- invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis[J]. Hepatogastroenterology,2009,56(94-95 ): 1459-1465.
  • 9Fung J, Lai CL, Fong DY, et al. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis[J]. Liver Int,2008,28(10): 1408- 1416.
  • 10Zhou K, Gao CF, Zhao YP, et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B [J]. J Gastroenterol Hepatol,2010,25(9): 1569-1577.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部